Medical agents acting on the renin-angiotensin-aldosterone axis for the treatment of heart failure

被引：0

作者：

Kawano, Hiroaki ^{[1
]}

Node, Koichi ^{[1
]}

机构：

[1] Saga Univ, Fac Med, Dept Cardiovasc & Renal Med, Saga 8498501, Japan

来源：

HYPERTENSION RESEARCH | 2010年 / 33卷 / 03期

关键词：

CONVERTING ENZYME-INHIBITORS; MYOCARDIAL-INFARCTION; MORTALITY; CAPTOPRIL; LOSARTAN; MORBIDITY;

D O I：

10.1038/hr.2009.232

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：192 / 193

页数：2

共 13 条

[1] Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial [J].

Dickstein, K ;

Kjekshus, J .

LANCET, 2002, 360 (9335) :752-760

[2]

FUSTER V, 2008, HURSTS HEART, P724

[3]

Hornig B, 1997, CIRCULATION, V95, P1115

[4] 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].

Jessup, Mariell ;

Abraham, William T. ;

Casey, Donald E. ;

Feldman, Arthur M. ;

Francis, Gary S. ;

Ganiats, Theodore G. ;

Konstam, Marvin A. ;

Mancini, Donna M. ;

Rahko, Peter S. ;

Silver, Marc A. ;

Stevenson, Lynne Warner ;

Yancy, Clyde W. ;

Hunt, Sharon Ann ;

Chin, Marshall H. .

CIRCULATION, 2009, 119 (14) :1977-2016

[5] Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure [J].

Lang, RM ;

Elkayam, U ;

Yellen, LG ;

Krauss, D ;

McKelvie, RS ;

Vaughan, DE ;

Ney, DE ;

Makris, L ;

Chang, PI .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (04) :983-991

[6]

LIBBY P, 2008, BROUNWALDS HEART DIS, P611

[7] Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure [J].

Matsumori, A .

EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (05) :669-677

[8] Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both [J].

Pfeffer, MA ;

McMurray, JJV ;

Velazquez, EJ ;

Rouleau, JL ;

Kober, L ;

Maggioni, AP ;

Solomon, SD ;

Swedberg, K ;

Van de Werf, F ;

White, H ;

Leimberger, JD ;

Henis, M ;

Edwards, S ;

Zelenkofske, S ;

Sellers, MA ;

Califf, RM ;

Aylward, P ;

Armstrong, P ;

Barvik, S ;

Belenkov, Y ;

Dalby, A ;

Diaz, R ;

Drexler, H ;

Ertl, G ;

Francis, G ;

Hampton, J ;

Harsanyi, A ;

Kvasnicka, J ;

Mareev, V ;

Marin-Neto, J ;

Murin, J ;

Myers, M ;

Nordlander, R ;

Opolski, G ;

Soler-Soler, J ;

Spac, J ;

Stefenelli, T ;

Sugrue, D ;

Van Gilst, W ;

Varshavsky, S ;

Weaver, D ;

Zannad, F ;

Aguilar, D ;

Alvarez, A ;

Al-Taweel, M ;

Anavekar, N ;

Finn, P ;

Lopez-Jimenez, F ;

Mercier, R ;

Lewis, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (20) :1893-1906

[9] Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the Losartan Heart Failure Survival Study ELITE II [J].

Pitt, B ;

Poole-Wilson, PA ;

Segal, R ;

Martinez, FA ;

Dickstein, K ;

Camm, AJ ;

Konstam, MA ;

Riegger, G ;

Klinger, GH ;

Neaton, J ;

Sharma, D ;

Thiyagarajan, B .

LANCET, 2000, 355 (9215) :1582-1587

[10] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].

Pitt, B ;

Remme, W ;

Zannad, F ;

Neaton, J ;

Martinez, F ;

Roniker, B ;

Bittman, R ;

Hurley, S ;

Kleiman, J ;

Gatlin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321

← 1 2 →